Results 21 to 30 of about 27,685 (249)

No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms [PDF]

open access: yes, 2007
Background The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of the simian T-cell lymphotropic ...
Burmeister, Thomas   +4 more
core   +2 more sources

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. [PDF]

open access: yes, 2014
BackgroundCanine cutaneous T-cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC-1101 (formerly known as GS-9219) has shown efficacy in dogs with multicentric lymphoma.
Burgess, KE   +5 more
core   +2 more sources

Protein and mRNA Expression Levels of Interleukin-17A, -17F and -22 in Blood and Skin Samples of Patients with Mycosis Fungoides

open access: yesActa Dermato-Venereologica, 2020
This study investigated the expression of interleukin (IL)-17A, -17F and -22 in mycosis fungoides. Blood samples were collected from 50 patients with mycosis fungoides and 50 healthy controls.
Despoina Papathemeli   +8 more
doaj   +1 more source

Childhood hypopigmented mycosis fungoides: a commonly delayed diagnosis [PDF]

open access: yes, 2014
Primary cutaneous lymphomas (PCLs) are exceedingly rare in children and adolescents, with mycosis fungoides (MF) being the most frequent PCL diagnosed in childhood. There are numerous unusual clinical variants of MF, including the hypopigmented type form
Gameiro, A   +3 more
core   +1 more source

Melanoma in patients with mycosis fungoides [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2021
The development of both malignant neoplasms mycosis fungoides and cutaneous malignant melanoma is a rare condition; nevertheless, the literature describes both cases of the development of mycosis fungoides in patients with a primary diagnosis of ...
Arfenya E. Karamova   +5 more
doaj   +1 more source

Efficacy of Narrowband UVB vs. PUVA in Patients with Early-Stage Mycosis Fungoides [PDF]

open access: yes, 2010
INTRODUCTION: Mycosis fungoides (MF) is a non-Hodgkin's T-cell lymphoma of the skin that often begins as limited patches and plaques with slow progression to systemic involvement.
Apetato, M, Ponte, P, Serrão, V
core   +1 more source

Eosinophils in the skin—a red herring masking lymphoma: a case series

open access: yesSAGE Open Medical Case Reports, 2018
Eosinophilia, both peripheral and in cutaneous tissue, is not a typical finding in mycosis fungoides; in fact, when faced with a lymphoeosinophilic infiltrate, mycosis fungoides is often not part of initial differential considerations.
Alejandra Jaque   +5 more
doaj   +1 more source

Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
BACKGROUND: Mycosis fungoides, the most common subtype of cutaneous T-cell lymphoma, is more common in patients aged 45-55.
Fatma Pelin Cengiz, Nazan Emiroglu
doaj   +1 more source

Mycosis fungoides with CD20 expression: report of two cases and review of the literature [PDF]

open access: yes, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107359/1/cup12299 ...
Arai   +27 more
core   +1 more source

Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A

open access: yesActa Dermato-Venereologica, 2018
Data on the treatment of early folliculotropic mycosis fungoides, a recently defined clinicopathological subgroup of folliculotropic mycosis fungoides with an indolent course, is limited.
Iris Amitay-Laish   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy